Intravenous arketamine for treatment-resistant depression: open-label pilot study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous arketamine for treatment-resistant depression: open-label pilot study
Authors
Keywords
-
Journal
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-20
DOI
10.1007/s00406-020-01110-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies
- (2020) Wei Zheng et al. JOURNAL OF AFFECTIVE DISORDERS
- Esketamine nasal spray approved for treatment-resistant depression
- (2019) Kate Traynor AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
- (2015) Ellen E. Lee et al. GENERAL HOSPITAL PSYCHIATRY
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Ketamine administration in depressive disorders: a systematic review and meta-analysis
- (2014) Guillaume Fond et al. PSYCHOPHARMACOLOGY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started